Perrigo Company (PRGO)
Россия
  • Россия
  • Украина

Perrigo Company (PRGO)

Contact Details

515 Eastern Ave, Allegan, Michigan, USA 49010-9070
(269) 673-8451
515 Eastern Ave, Allegan, Michigan, USA 49010-9070

General Information

Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.

Contact Information

Phone(269) 673-8451
Customer Service Phone(800) 879-3477
Fax(269) 673-1198
Website 1http://www.perrigo.com
FacebookFacebook
LinkedInLinkedIn
Twitter@PerrigoCompany
Thomson Reuters PermID5040203322

Executives

NamePositionTotal Annual CompensationYearPercent Change in Compensation
CEO, Chairman of the Board and President$9,707,6192015-48.8%

Government Contracts

Largest Contracts

AgencyProduct or ServiceSigned DateObligation Amount
Farm Service AgencyDairy Foods and EggsFebruary 14, 2013$0
Department of Veterans AffairsDrugs and BiologicalsAugust 17, 2011$0
Department of Veterans AffairsDrugs and BiologicalsFebruary 28, 2007$0

Corporate Data

Industries

  • Pharmaceutical Preparation Manufacturing

SIC Industries

  • Pharmaceutical Preparations

Company Size

Sales Volume$5.35 billion
Employees13,500

Ownership

Ticker SymbolPRGO
ExchangeNew York Stock Exchange (NYSE)
Type of EntityFor Profit Organization
Type of Ownership
  • Limited Liability Corporation
  • Not Tax Exempt Corporate Entity
  • Other Business or Organization
  • Partnership or Limited Liability Partnership
Other CategorizationsManufacturer of Goods
Year Founded1987

Stocks

Previous Close128.70
Open129.61
Bid127.21 x 200
Ask127.30 x 700
Day`s Range125.05 - 129.66
52-Week Range124.08 - 203.69
Average Volume (1M)1,590,429
Forward P/E13.49x
Trailing P/E16.96x
Beta0.29x
Market Cap.$18,430.1 Million
Dividend & Yield0.58 (0.45%)
Last Dividend Amount0.13
1y Target Price Est.196.22

Financials

Period EndingDec. 31, 2015Sep. 30, 2015Jun. 30, 2015Mar. 31, 2015
Total Revenue1,424,8001,344,700-1,049,100
Cost of Revenue865,500795,900-670,300
Gross Profit559,300548,799.9-378,800
Research Development46,60041,600-35,400
Selling General and Administrative366,400316,400-143,100
Depreciation and Amortization----
Other Operating Expenses240,3002,200-1,100
Total Operating Expenses1,518,8001,156,100-849,900
Other Income/Expenses Net----
Earnings Before Interest and Taxes(93,999.9)188,600-199,200
Interest Expense46,50043,400-43,300
Income Before Tax(155,400)132,200-(102,700)
Income Tax Expense(48,400)19,600-(7,800)
Minority Interest----
Net Income from Continuing Ops(107,000)112,600-(94,900)
Discontinued Operations----
Extraordinary Items----
Effect of Accounting Changes----
Other Items----
Net Income(107,000)112,600-(94,900)
Preferred Stock and Other Adjustments----
Net Income Applicable to Common Shares(107,000)112,600-(94,900)